Blocking of Pseudomonas aeruginosa and Chromobacterium violaceum lectins by diverse mammalian milks

K D Zinger-Yosovich1, D Iluz, D Sudakevitz

  • 1The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan 52900, Israel.

Journal of Dairy Science
|January 29, 2010
PubMed

Insights

Human milk effectively blocks bacterial adhesion by inhibiting pathogen lectins, outperforming cow milk. This study highlights milk

Area of Science:

  • Microbiology
  • Biochemistry
  • Immunology

Background:

  • Bacterial infections caused by Pseudomonas aeruginosa and Chromobacterium violaceum rely on lectins for host cell attachment and biofilm formation.
  • Antibiotic resistance in these pathogens necessitates novel therapeutic strategies, such as glycodecoys to block lectin-mediated adhesion.

Purpose of the Study:

  • To compare the anti-lectin-dependent adhesion potential of various mammalian milks using bacterial lectins as probes.
  • To evaluate the efficacy of different milks in blocking the adhesion of specific bacterial lectins (PA-IL, PA-IIL, CV-IIL).

Main Methods:

  • Utilized bacterial lectins (PA-IL, PA-IIL, CV-IIL) and plant lectin (concanavalin A) to assess milk's inhibitory effects.
  • Employed hemagglutination inhibition and Western blot assays to measure lectin binding and inhibition by diverse milks.

Main Results:

  • Human milk demonstrated the strongest inhibition of all three bacterial lectins, followed by alpaca, giraffe, and monkey milks. Cow milk showed weak inhibition.
  • Individual lectins exhibited differential sensitivity to milks; PA-IL was strongly inhibited by human and alpaca milk, while PA-IIL and CV-IIL were most sensitive to human milk.
  • Plant lectin concanavalin A showed different inhibition patterns, being less sensitive to human milk and equally sensitive to cow milk compared to bacterial lectins.

Conclusions:

  • Diverse mammalian milks possess varying capacities to block lectin-dependent bacterial adhesion, with human and alpaca milks being particularly effective.
  • Isolated pathogenic bacterial lectins serve as valuable tools for identifying glycodecoys that can inhibit bacterial adhesion and potentially combat antibiotic-resistant infections.
  • The findings suggest that specific milk components or glycans could be developed as therapeutic agents against infections caused by antibiotic-resistant bacteria.